X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2919) 2919
Book Review (826) 826
Publication (167) 167
Book Chapter (15) 15
Conference Proceeding (4) 4
Magazine Article (4) 4
Dissertation (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2620) 2620
humans (2112) 2112
diabetes mellitus, type 2 - drug therapy (1429) 1429
male (1288) 1288
animals (1131) 1131
dipeptidyl-peptidase iv inhibitors - therapeutic use (1083) 1083
type 2 diabetes (969) 969
endocrinology & metabolism (856) 856
female (852) 852
hypoglycemic agents - therapeutic use (829) 829
diabetes (791) 791
glucagon-like peptide-1 (765) 765
pharmacology & pharmacy (665) 665
middle aged (664) 664
dipeptidyl-peptidase iv inhibitors - pharmacology (620) 620
dipeptidyl peptidase 4 - metabolism (552) 552
dipeptidyl-peptidase iv inhibitors - administration & dosage (552) 552
sitagliptin (528) 528
dipeptidyl-peptidase iv inhibitors - adverse effects (522) 522
aged (515) 515
glucose (501) 501
rats (498) 498
mice (458) 458
treatment outcome (450) 450
adamantane - analogs & derivatives (442) 442
diabetes mellitus, type 2 - blood (431) 431
hypoglycemic agents - administration & dosage (427) 427
adult (418) 418
hypoglycemic agents - adverse effects (400) 400
double-blind (395) 395
hypoglycemic agents (391) 391
insulin (389) 389
blood glucose - metabolism (388) 388
glycemic control (374) 374
dipeptidyl peptidase-4 inhibitor (373) 373
metformin (371) 371
drug therapy, combination (360) 360
analysis (359) 359
blood glucose - drug effects (350) 350
care and treatment (332) 332
diabetes mellitus (331) 331
sitagliptin phosphate (328) 328
vildagliptin (319) 319
hypoglycemic agents - pharmacology (308) 308
research (299) 299
drug therapy (298) 298
type-2 diabetes-mellitus (281) 281
internal medicine (273) 273
peptides (273) 273
risk factors (271) 271
glp-1 (265) 265
dextrose (261) 261
glucagon (255) 255
diabetes therapy (252) 252
safety (252) 252
type 2 diabetes mellitus (244) 244
beta-cell function (241) 241
dpp-4 inhibitor (238) 238
administration, oral (237) 237
abridged index medicus (236) 236
diabetes mellitus, type 2 - complications (235) 235
adamantane - therapeutic use (231) 231
dosage and administration (229) 229
dipeptidyl peptidase-4 inhibitors (228) 228
peptidase (226) 226
dipeptidyl-peptidase-iv (225) 225
efficacy (225) 225
metformin - therapeutic use (224) 224
diabetes mellitus, type 2 - metabolism (220) 220
double-blind method (217) 217
glycated hemoglobin a - metabolism (216) 216
dose-response relationship, drug (211) 211
biochemistry & molecular biology (209) 209
medicine, general & internal (208) 208
dipeptidyl-peptidase iv inhibitors - pharmacokinetics (198) 198
dipeptidyl peptidase-iv (197) 197
dipeptidyl-peptidase iv inhibitors (196) 196
linagliptin (196) 196
health aspects (195) 195
medicine, research & experimental (192) 192
improves glycemic control (190) 190
medicine & public health (189) 189
dipeptidyl peptidase iv (186) 186
pharmacokinetics (184) 184
clinical trials (183) 183
hyperglycemia (183) 183
mellitus (182) 182
insulin resistance (181) 181
triazoles - therapeutic use (178) 178
pyrazines - therapeutic use (175) 175
dpp-4 inhibitors (173) 173
insulin - metabolism (173) 173
mice, inbred c57bl (172) 172
time factors (171) 171
physiological aspects (168) 168
glucagon-like peptide 1 (166) 166
therapy (163) 163
cardiac & cardiovascular systems (161) 161
glucagon-like peptide-1 receptor (161) 161
pyrrolidines - therapeutic use (159) 159
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2865) 2865
Japanese (18) 18
French (12) 12
German (8) 8
Spanish (7) 7
Hungarian (5) 5
Russian (4) 4
Chinese (2) 2
Danish (2) 2
Korean (2) 2
Croatian (1) 1
Czech (1) 1
Dutch (1) 1
Italian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetologia, ISSN 0012-186X, 11/2017, Volume 60, Issue 11, pp. 2285 - 2298
The main aims of the present study were: (1) to assess the expression and content of dipeptidyl peptidase IV (DPP-IV) in human and db/db mouse retinas, and in... 
Diabetic retinopathy | GLP-1 | Medicine & Public Health | Human Physiology | Metabolic Diseases | DPP-IV inhibitors | Internal Medicine | Retinal neurodegeneration | Experimental diabetes | CELLS | EXENDIN-4 ANALOG | PROTECTION | RATS | BARRIER BREAKDOWN | VASCULAR LEAKAGE | DPP-IVinhibitors | EARLY EVENT | INFLAMMATION | ENDOCRINOLOGY & METABOLISM | VE-CADHERIN | RETINOPATHY | Electroretinography | Immunohistochemistry | Retina - drug effects | Diabetes Mellitus, Experimental - drug therapy | Dipeptides - therapeutic use | Glucagon-Like Peptide 1 - metabolism | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Male | Animals | Adamantane - therapeutic use | Sitagliptin Phosphate - therapeutic use | Mice | Retina - pathology | Adamantane - analogs & derivatives | Diabetes Mellitus, Experimental - physiopathology | Prevention | Type 2 diabetes | Analysis | CD26 antigen | Calcium | Glucagon | Liver | Retina | mRNA | Western blotting | Eye | Proteins | Neurodegeneration | Protein folding | Intestine | Rodents | Collagen (type IV) | Glucagon-like peptide 1 | Enzyme-linked immunosorbent assay | Leakage | Peptidase | Glial fibrillary acidic protein | Diabetes mellitus | Albumin | Epithelium | High-performance liquid chromatography | Polymerase chain reaction | Diabetes | Receptor mechanisms | Immunofluorescence | Apoptosis | Index Medicus
Journal Article
Diabetes care, ISSN 0149-5992, 03/2015, Volume 38, Issue 3, pp. 384 - 393
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 02/2012, Volume 340, Issue 2, pp. 248 - 255
Dipeptidyl peptidase (DPP) IV inhibitors are probably beneficial for preventing diabetic complication and modulating glucagon-like peptide-1 receptor (GLP-1R)... 
FIBROSIS | GROWTH-FACTOR-BETA | TGF-BETA | GLP-1 | GLUCAGON-LIKE PEPTIDE-1 | GLUCOSE-METABOLISM | BETA-CELL APOPTOSIS | RECEPTOR EXPRESSION | IMPROVES | PHARMACOLOGY & PHARMACY | NEPHROPATHY | Diabetes Mellitus, Experimental - drug therapy | Dipeptidyl Peptidase 4 - metabolism | Gene Expression - drug effects | Kidney - pathology | Gene Expression - genetics | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Transforming Growth Factor beta1 - metabolism | Caspase 3 - metabolism | Body Weight - drug effects | Diabetic Nephropathies - drug therapy | Pyrrolidines - administration & dosage | Glucagon-Like Peptide 1 - blood | Male | Insulin - blood | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Pyrrolidines - pharmacology | Pyrrolidines - therapeutic use | Kidney - metabolism | Diabetic Nephropathies - physiopathology | Glomerular Basement Membrane - pathology | Adamantane - therapeutic use | Diabetes Mellitus, Experimental - complications | Adamantane - administration & dosage | Cyclic AMP - urine | Deoxyguanosine - analogs & derivatives | Kidney - physiopathology | Adamantane - analogs & derivatives | Diabetes Mellitus, Experimental - physiopathology | Receptors, Glucagon - genetics | Adamantane - pharmacology | Diabetic Nephropathies - pathology | Kidney - drug effects | Deoxyguanosine - urine | Diabetic Nephropathies - metabolism | Rats | Receptors, Glucagon - metabolism | Rats, Sprague-Dawley | Dipeptidyl-Peptidase IV Inhibitors - administration & dosage | Blood Glucose - drug effects | Eating - drug effects | Glomerular Basement Membrane - drug effects | Animals | Glucagon-Like Peptide-1 Receptor | Diabetes Mellitus, Experimental - pathology | Blood Glucose - metabolism | Index Medicus
Journal Article
Diabetic Medicine, ISSN 0742-3071, 11/2011, Volume 28, Issue 11, pp. 1352 - 1361
Aims To examine the efficacy and safety of the dipeptidyl peptidase-4 inhibitor linagliptin in persons with Type 2 diabetes mellitus inadequately controlled... 
metformin | linagliptin | dipeptidyl peptidase‐4 inhibitor | sulphonylurea | Type 2 diabetes | Type 2 diabetes | GLYCEMIC CONTROL | DIPEPTIDYL-PEPTIDASE-4 INHIBITOR | CONSENSUS | dipeptidyl peptidase-4 inhibitor | PHARMACODYNAMICS | MELLITUS | BETA-CELL FUNCTION | ADD-ON THERAPY | PHARMACOKINETICS | ENDOCRINOLOGY & METABOLISM | BI 1356 | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Glycated Hemoglobin A - drug effects | Male | Purines - administration & dosage | Young Adult | Hypoglycemic Agents - administration & dosage | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Linagliptin | Purines - adverse effects | Purines - therapeutic use | Sulfonylurea Compounds - administration & dosage | Metformin - administration & dosage | Drug Therapy, Combination | Body Mass Index | Hypoglycemic Agents - therapeutic use | Fasting | Double-Blind Method | Treatment Outcome | Biomarkers - blood | Dipeptidyl-Peptidase IV Inhibitors - administration & dosage | Diabetes Mellitus, Type 2 - blood | Quinazolines - therapeutic use | Adolescent | Quinazolines - adverse effects | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Analysis | Hypoglycemic agents | Glucose | Diabetes | Research | Dextrose | Diabetes therapy | Index Medicus
Journal Article
Circulation, ISSN 0009-7322, 2014, Volume 130, Issue 18, pp. 1579 - 1588
Journal Article
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2012, Volume 59, Issue 3, pp. 265 - 276
Journal Article
by Fadini, Gian Paolo and Avogaro, Angelo and Degli Esposti, Luca and Russo, Pierluigi and Saragoni, Stefania and Buda, Stefano and Rosano, Giuseppe and Pecorelli, Sergio and Pani, Luca and Martinetti, S and Mero, P and Ræli, L and Migliazza, S and Dellagiovanna, M and Cerra, C and Gambera, M and Piccinelli, R and Zambetti, M and Atzeni, F and Valsecchi, V and Deluca, P and Scopinaro, E and Moltoni, D and Pini, E and Leoni, O and Oria, C and Papagni, M and Nosetti, G and Caldiroli, E and Moser, V and Roni, R and Polverino, A and Bovo, C and Mezzalira, L and Andretta, M and Trentin, L and Palcic, S and Pettinelli, A and Arbo, A and Bertola, A and Capparoni, G and Cattaruzzi, C and Marcuzzo, L and Rosa, F.V and Basso, B and Saglietto, M and Delucis, S and Prioli, M and Filippi, R and Coccini, A and Ghia, M and Sanfelici, F and Radici, S and Scanavacca, P and Campi, A and Bianchi, S and Verzola, A and Morini, M and Borsari, M and Danielli, A and Dal Maso, M and Marsiglia, B and Vujovic, B and Pisani, M and Bonini, P and Lena, F and Aletti, P and Marcobelli, A and Sagratella, S and Fratini, S and Bartolini, F and Riccioni, G and Meneghini, A and Di Turi, R and Fano, V and Blasi, A and Pagnozzi, E and Quintavalle, G and D'Avenia, P and De Matthæis, M.C and Ferrante, F and Crescenzi, S and Marziale, L and Venditti, P and Bianchi, C and Senesi, I and Baci, R and De Carlo, I and Lavalle, A and Trofa, G and Marcello, G and Pagliaro, C and Troncone, C and Farina, G and Tari, M.G and Motola, G and De Luca, F and Saltarelli, M.L and Granieri, C and Vulnera, M and ... and OsMed Hlth-DB Network and OsMed Health-DB Network
European Heart Journal, ISSN 0195-668X, 09/2015, Volume 36, Issue 36, pp. 2454 - 2462
Journal Article
Journal Article